Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application

OBJECTIVE: Chimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies are promising, there are concerns about commercial products regarding their affordability and sustainability. In this preliminary study, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Erdoğan, Ebru, Yalçın, Koray, Hemşinlioğlu, Cansu, Sezgin, Aslıhan, Seyis, Utku, Kancağı, Derya Dilek, Taştan, Cihan, Yurtsever, Bulut, Turan, Raife Dilek, Çakırsoy, Didem, Abanuz, Selen, Sır Karakuş, Gözde, Elek, Muhammer, Beköz, Hüseyin Saffet, Gemici, Ali İhsan, Sargın, Deniz, Arat, Mutlu, Ferhanoğlu, Burhan, Pekgüç, Ebru, Örnek, Serdar, Büyüktaş, Deram, Birgen, Nur, Ratip, Siret, Ovalı, Ercüment
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421334/
https://www.ncbi.nlm.nih.gov/pubmed/35848614
http://dx.doi.org/10.4274/tjh.galenos.2022.2022.0193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421334/
https://www.ncbi.nlm.nih.gov/pubmed/35848614
http://dx.doi.org/10.4274/tjh.galenos.2022.2022.0193

Ejemplares similares